The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).

The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).
复制标题

DOI:
10.3390/ijms21176412
复制
发表时间:
2020-09-03
影响因子:
5.6
通讯作者:
Yu AM
Yu AM
中科院分区:
生物学2区
文献类型:
--
作者:
Batra N;De Souza C;Batra J;Raetz AG;Yu AM

文献摘要

参考文献

被引文献

相似文献

2019冠状病毒病(COVID-19)或严重急性呼吸系统综合征冠状病毒2(SARS-CoV-2)感染是一种全球性大流行病,发病率和死亡率不断上升。基于严重COVID-19病例细胞因子谱的最新证据表明,在感染SARS-CoV-2的患者中,巨噬细胞和单核细胞的过度刺激与T细胞丰度降低(淋巴细胞减少症)相关。通过高通量筛选实验发现SARS-CoV-2开放阅读框3a(ORF 3a)蛋白以高置信度与人HMOX 1蛋白结合。HMOX 1通路可以抑制血小板聚集,并且可以具有抗血栓形成和抗炎特性等,所有这些都是在COVID-19患者中观察到的关键医学病症。在这里,我们回顾了调节HMOX 1-ORF 3a关系以调节先天免疫应答以获得COVID-19患者治疗益处的潜力。我们还审查了其他潜在的治疗策略,并提出了新的合成和天然化合物,可能有潜力在临床上的未来发展。
The coronavirus disease of 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global pandemic with increasing incidence and mortality rates. Recent evidence based on the cytokine profiles of severe COVID-19 cases suggests an overstimulation of macrophages and monocytes associated with reduced T-cell abundance (lymphopenia) in patients infected with SARS-CoV-2. The SARS-CoV-2 open reading frame 3 a (ORF3a) protein was found to bind to the human HMOX1 protein at a high confidence through high-throughput screening experiments. The HMOX1 pathway can inhibit platelet aggregation, and can have anti-thrombotic and anti-inflammatory properties, amongst others, all of which are critical medical conditions observed in COVID-19 patients. Here, we review the potential of modulating the HMOX1-ORF3a nexus to regulate the innate immune response for therapeutic benefits in COVID-19 patients. We also review other potential treatment strategies and suggest novel synthetic and natural compounds that may have the potential for future development in clinic.
DOI: 10.1186/s12943-018-0915-9
发表时间: 2018-11-22
期刊: Molecular cancer
影响因子: 37.3
作者:
Donati B;Lorenzini E;Ciarrocchi A
通讯作者: Ciarrocchi A
DOI: 10.1172/jci32730
发表时间: 2008-01-01
影响因子: 15.9
作者:
Chung, Su Wol;Liu, Xiaoli;Perrella, Mark A.
通讯作者: Perrella, Mark A.
DOI: 10.2174/157015908787386113
发表时间: 2008-12
影响因子: 5.3
作者:
Cobos EJ;Entrena JM;Nieto FR;Cendán CM;Del Pozo E
通讯作者: Del Pozo E
DOI: 10.1172/jci137244
发表时间: 2020-05-01
影响因子: 15.9
作者:
Chen, Guang;Wu, Di;Ning, Qin
通讯作者: Ning, Qin
DOI: 10.1002/jmv.26288
发表时间: 2020-07-15
影响因子: 12.7
作者:
Antony, Suresh J.;Davis, Michelle A.;Prakash, Bharat, V
通讯作者: Prakash, Bharat, V